Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
09/2003
09/04/2003CA2476896A1 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
09/04/2003CA2476518A1 Compositions and methods for the treatment of immune related diseases
09/04/2003CA2476316A1 Beta3-adrenergic receptor agonists
09/04/2003CA2476173A1 Arylsulfone derivatives
09/04/2003CA2475299A1 Thiazole derivatives as npy receptor antagonists
09/04/2003CA2459155A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
09/03/2003EP1340979A2 Neuropeptide receptor and uses thereof
09/03/2003EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/03/2003EP1340505A2 Therapeutic use of cis-element decoys in vivo
09/03/2003EP1340500A1 Antidiabetic agents
09/03/2003EP1339842A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339737A2 Immunomodulatory protein derived from the yaba monkey tumor virus
09/03/2003EP1339719A1 Benzimidazole derivatives, preparation and therapeutic use thereof
09/03/2003EP1339716A1 Novel lactame-substituted pyrazolopyridine derivatives
09/03/2003EP1339711A1 Aminothiazoles and their use as adenosine receptor antagonists
09/03/2003EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands
09/03/2003EP1339694A1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists
09/03/2003EP1339691A1 Novel compounds
09/03/2003EP1339683A2 Estrogen receptor modulators
09/03/2003EP1339682A1 1,4-disubstituted piperazine derivatives useful as uro-selective $g(a)1-adrenoceptor blockers
09/03/2003EP1339679A1 3-arylindole derivatives and their use as cb2 receptor agonists
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/03/2003EP1339458A2 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity
09/03/2003EP1339425A2 Vaccine composition containing transforming growth factor alpha
09/03/2003EP1339410A1 Use of pyrazolo 4,3-d]pyrimidines
09/03/2003EP1339406A2 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders
09/03/2003EP1339402A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
09/03/2003EP1095038B1 Antagonists of gonadotropin releasing hormone
09/03/2003EP1070065B1 Azabicyclic 5ht1 receptor ligands
09/03/2003EP0876359B1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
09/03/2003EP0797435B1 Controlled release matrix for pharmaceuticals
09/03/2003EP0767798B1 Sterol derivatives used for regulation of meiosis
09/03/2003CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof
09/03/2003CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/03/2003CN1440405A Sulfonyl-pyrrolidine derivatives useful for treatment of neurological disorders
09/03/2003CN1440395A COLCHINOL derivatives as vascular damaging agents
09/03/2003CN1440388A Beta crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same
09/03/2003CN1440387A Alpha crystalline form of perindopril tert-butyllamine salt
09/03/2003CN1440386A Gamma crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same
09/03/2003CN1440283A Combination of organic compounds
09/03/2003CN1439422A Prescription for nephritis
09/03/2003CN1439402A Chinese medicinal herb preparation for lithangiuria
09/03/2003CN1439364A Protective composite amino acid composition for kidney and its use
09/03/2003CN1120011C Chinese herb medicine composition for treating glomerulonephritis
09/03/2003CN1120005C Chinese medicinal preparation of irritable purpuric nephritis
09/02/2003US6613891 Polynucleotides that encode bovine inhibin
09/02/2003US6613802 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/02/2003US6613801 Method for the synthesis of compounds of formula I and their uses thereof
09/02/2003US6613796 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
09/02/2003US6613772 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments
09/02/2003US6613760 Indole derivatives and their use as MCP-1 receptor antagonists
09/02/2003US6613757 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
09/02/2003US6613739 Immunosuppressants
09/02/2003US6613737 Fractionating serum/blood plasma by chromatography and electrophoresis; sperm-motility promoting glycoprotein
09/02/2003US6613328 Methods of treating thrombotic diseases with von Willebrand factor specific antibodies
09/02/2003CA2216796C Quinazoline derivatives
08/2003
08/28/2003WO2003070970A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA)
08/28/2003WO2003070968A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070918A2 Rna interference by modified short interfering nucleic acid
08/28/2003WO2003070914A2 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070911A2 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r)
08/28/2003WO2003070910A2 INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VEGF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070903A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070886A2 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid
08/28/2003WO2003070765A2 Growth hormone fusion protein
08/28/2003WO2003070744A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070727A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003WO2003070711A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
08/28/2003WO2003070707A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
08/28/2003WO2003070675A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
08/28/2003WO2003070245A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
08/28/2003WO2003070236A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003WO2003070235A1 Medicinal compositions for inhibiting tryptase
08/28/2003WO2003070233A1 Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence
08/28/2003WO2003070197A2 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070188A2 Method of treating trx mediated diseases
08/28/2003WO2003070166A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003WO2003070157A2 Vitamin d upregulated protein 1 (vdup-1) methods and uses thereof
08/28/2003WO2003070153A2 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
08/28/2003WO2003070023A1 Amino acid powder and process for producing the same
08/28/2003WO2003031447A3 Pyrimidine derivatives
08/28/2003WO2003013434A3 Methods and compositions for treating diseases associated with excesses in ace
08/28/2003WO2002096468A3 Method for the diagnosis and therapy of renal cell carcinoma
08/28/2003WO2002094192A3 Antibodies against tumor necrosis factor delta (april)
08/28/2003WO2002081521A3 Osteoprotegerin in milk
08/28/2003WO2002081508A3 Use of cd25 binding molecules in steroid-resistant patients
08/28/2003WO2002041880A3 Use of pyrazolo[4,3-d]pyrimidines
08/28/2003WO2002012326A3 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
08/28/2003WO2001095859A3 Novel heterocyclic analogs of diphenylethylene compounds
08/28/2003WO2001085147A3 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO[b]THIOPHENE AND SALTS THEREOF
08/28/2003US20030163845 Elongase genes and uses thereof
08/28/2003US20030163834 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
08/28/2003US20030162969 Process and intermediates for pyridazinone antidiabetic agents
08/28/2003US20030162968 1,4-Disubstituted benzo-fused urea compounds
08/28/2003US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
08/28/2003US20030162823 Novel C-4 substituted retinoids
08/28/2003US20030162780 Administering to a patient with a disease treatable with a muscarinic receptor antagonist a 1,2,3,4-tetrahydro-naphthalene-2-yl-alkylaminoalkyl-piperidine derivative
08/28/2003US20030162779 4-oxo-4H-thiazole derivative for treating or preventing neurodegenerative disorders
08/28/2003US20030162777 Administering a biheterocyclic compounds containing aminocarbonyl, aminothiocarbonyl or aminosulfonyl group for treating neuromuscular dysfunction of the lower urinary tract in a mammal in need of such treatment
08/28/2003US20030162767 Novel 1,3-dihydro-2h-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them
1 ... 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 ... 562